Pharma and Biotech (DLS30)

 0.00
   
  • 52 Week High: NULL
  • 52 Week Low: 0.00

Latest ShareCast News

Aptamer wins contract with 'top 10' repeat customer

By Benjamin Chiou

Date: Monday 13 Oct 2025

(Sharecast News) - Life sciences group Aptamer on Monday announced a new fee-for-service development contract with an unnamed top 10 global pharma company.

AstraZeneca to cut US drug prices in key White House deal

By Abigail Townsend

Date: Monday 13 Oct 2025

(Sharecast News) - AstraZeneca has struck a deal with the White House to cut drugs prices in America, allowing it to avoid steep tariffs on US imports.

Sareum halts toxicology study after control-group safety findings

By Iain Gilbert

Date: Friday 10 Oct 2025

(Sharecast News) - Clinical-stage biotechnology firm Sareum said on Friday that it has discontinued its 16-week pre-clinical toxicology study for autoimmune and cancer candidate SDC-1801 after safety issues were flagged by a third-party provider.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 0.00
Closing Price Change 0.00
% Change 0.00 %
--25 Close 0.00

Top Risers

Price Change
VRCI 0.90p +16.1%
GNS 2,650.00p +4.1%
GUN 0.16p +3.2%
SCLP 10.00p +2.6%
PRTC 133.00p +1.8%
AVCT 71.00p +1.4%
POLB 3.60p +1.4%
HLN 342.10p +1.0%
OXB 647.00p +0.6%
GSK 1,627.50p +0.2%

Top Fallers

Price Change
FUM 2.00p -14.9%
NFX 0.23p -13.2%
PRM 1.87p -8.4%
GENF 2.00p -6.5%
SAR 14.50p -6.5%
IMM 10.40p -6.3%
APTA 0.99p -5.7%
AGY 8.00p -5.3%
OPTI 9.75p -4.9%
SVNS 0.36p -4.1%

Top of Page